The addition of anti-angiogenic tyrosine kinase inhibitors to chemotherapy for patients with advanced non-small-cell lung cancers: A meta-analysis of randomized trials

Lung Cancer ◽

10.1016/j.lungcan.2016.10.004 ◽

2016 ◽

Vol 102 ◽

pp. 21-27 ◽

Author(s):

Bob T. Li ◽

Tristan A. Barnes ◽

David L. Chan ◽

Jarushka Naidoo ◽

Adrian Lee ◽

...

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitors ◽

Randomized Trials ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Small Cell Lung ◽

Download Full-text

358P Adjuvant tyrosine kinase inhibitors in non-squamous non-small cell lung cancer with EGFR driver mutations: An updated meta-analysis of randomized trials

Annals of Oncology ◽

10.1016/j.annonc.2020.10.351 ◽

2020 ◽

Vol 31 ◽

pp. S1379

Author(s):

J.C. Balolong-Garcia ◽

J.G.P. Pandy

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitors ◽

Randomized Trials ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Driver Mutations ◽

Small Cell Lung

Download Full-text

VEGFR2 blockade augments the effects of tyrosine kinase inhibitors by inhibiting angiogenesis and oncogenic signaling in oncogene‐driven non‐small‐cell lung cancers

Cancer Science ◽

10.1111/cas.14801 ◽

2021 ◽

Author(s):

Hiromi Watanabe ◽

Eiki Ichihara ◽

Hiroe Kayatani ◽

Go Makimoto ◽

Kiichiro Ninomiya ◽

...

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitors ◽

Kinase Inhibitors ◽

Small Cell Lung ◽

Oncogenic Signaling ◽

Download Full-text

Multi-targeted tyrosine kinase inhibitors as third-line regimen in advanced non-small cell lung cancer: a network meta-analysis

Annals of Translational Medicine ◽

10.21037/atm.2019.08.51 ◽

2019 ◽

Vol 7 (18) ◽

pp. 452-452 ◽

Author(s):

Zhonghan Zhang ◽

Yuanyuan Zhao ◽

Feiteng Lu ◽

Xue Hou ◽

Yuxiang Ma ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitors ◽

Cell Lung Cancer ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Small Cell Lung ◽

Download Full-text

MERTK Promotes Resistance to Irreversible EGFR Tyrosine Kinase Inhibitors in Non–small Cell Lung Cancers Expressing Wild-type EGFR Family Members

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-18-0040 ◽

2018 ◽

Vol 24 (24) ◽

pp. 6523-6535 ◽

Author(s):

Dan Yan ◽

Rebecca E. Parker ◽

Xiaodong Wang ◽

Stephen V. Frye ◽

H. Shelton Earp ◽

...

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitors ◽

Kinase Inhibitors ◽

Wild Type ◽

Small Cell Lung ◽

Lung Cancers ◽

Egfr Tyrosine Kinase ◽

Egfr Tyrosine Kinase Inhibitors ◽

Download Full-text

Efficacy of EGFR Tyrosine Kinase Inhibitors in the Adjuvant Treatment for Operable Non-small Cell Lung Cancer by a Meta-Analysis

CHEST Journal ◽

10.1016/j.chest.2015.12.017 ◽

2016 ◽

Vol 149 (6) ◽

pp. 1384-1392 ◽

Author(s):

Qingyuan Huang ◽

Jinhui Li ◽

Yihua Sun ◽

Rui Wang ◽

Xinghua Cheng ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitors ◽

Adjuvant Treatment ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitors

Download Full-text

ROS1 protein-tyrosine kinase inhibitors in the treatment of ROS1 fusion protein-driven non-small cell lung cancers

Pharmacological Research ◽

10.1016/j.phrs.2017.04.022 ◽

2017 ◽

Vol 121 ◽

pp. 202-212 ◽

Author(s):

Robert Roskoski

Keyword(s):

Fusion Protein ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitors ◽

Protein Tyrosine Kinase ◽

Kinase Inhibitors ◽

Small Cell Lung ◽

Lung Cancers ◽

Protein Tyrosine

Download Full-text

Efficacy and safety of chemotherapy or tyrosine kinase inhibitors combined with bevacizumab versus chemotherapy or tyrosine kinase inhibitors alone in the treatment of non-small cell lung cancer: a systematic review and meta-analysis

Medical Oncology ◽

10.1007/s12032-014-0473-y ◽

2015 ◽

Vol 32 (2) ◽

Author(s):

Li Sun ◽

Jie-Tao Ma ◽

Shu-Ling Zhang ◽

Hua-Wei Zou ◽

Cheng-Bo Han

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitors ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Efficacy And Safety ◽

Small Cell Lung

Download Full-text

Genetic alterations and protein expression in combined small cell lung cancers and small cell lung cancers arising from lung adenocarcinomas after therapy with tyrosine kinase inhibitors

10.18632/oncotarget.9083 ◽

2016 ◽

Vol 7 (23) ◽

pp. 34240-34249 ◽

Author(s):

Xiaohua Shi ◽

Huanli Duan ◽

Xuguang Liu ◽

Liangrui Zhou ◽

Zhiyong Liang

Keyword(s):

Protein Expression ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitors ◽

Kinase Inhibitors ◽

Genetic Alterations ◽

Small Cell Lung ◽

Lung Cancers ◽

Lung Adenocarcinomas

Download Full-text

Differential effects of adjuvant EGFR tyrosine kinase inhibitors in patients with different stages of non-small-cell lung cancer after radical resection: an updated meta-analysis

Cancer Management and Research ◽

10.2147/cmar.s187940 ◽

2019 ◽

Vol Volume 11 ◽

pp. 2677-2690 ◽

Author(s):

Di Lu ◽

Zhizhi Wang ◽

Xiguang Liu ◽

Siyang Feng ◽

Xiaoying Dong ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitors ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Radical Resection ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitors

Download Full-text

Erratum to: Different efficacy of EGFR tyrosine kinase inhibitors and prognosis in patients with subtypes of EGFR-mutated advanced non-small cell lung cancer: a meta-analysis

Journal of Cancer Research and Clinical Oncology ◽

10.1007/s00432-014-1825-x ◽

2014 ◽

Vol 140 (11) ◽

pp. 1911-1911 ◽

Author(s):

Huan Wang ◽

Jing Huang ◽

Xiaojin Yu ◽

Shuhua Han ◽

Xing Yan ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitors ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitors ◽

Download Full-text